Stocks making the biggest moves midday: Affirm, General Motors, Apple and more
Check out the companies making headlines in midday trading. Affirm Holdings – The stock popped nearly 7% following the announcement that its buy now,
Fed meeting and inflation report both hit Wednesday, and the impact could be huge
Wednesday is shaping up to be one of the most important days of the year for economic news, as investors will hear about the
UAW President Shawn Fain under investigation by federal monitor
Shawn Fain, who led the United Auto Workers union in its strike against all three unionized American automakers last fall, is under investigation by
Urban One, Inc. (UONE) Q4 2023 and Q1 2024 Earnings Call Transcript
Urban One, Inc. (NASDAQ:UONE) Q4 2023 and Q1 2024 Earnings Conference Call June 10, 2024 4:30 PM ET Company Participants Alfred Liggins – Chief
Juror details to CNN how Hunter Biden guilty verdict happened
The jury in the Hunter Biden gun case was deadlocked in an initial vote Monday night over whether to convict the president’s son, one
This week's personal loan rates rise for 3-year loans, while 5-year terms edge down
Our goal here at Credible Operations, Inc., NMLS Number 1681276, referred to as “Credible” below, is to give you the tools and confidence you
Power stocks up, SaaS challenges and awaiting AI updates at Apple’s big event
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour
Trump Media shares fall after new SEC filing with reaudited financial statement
Trump Media on Monday submitted an updated inspection of the company’s finances by a newly hired public accounting firm, after its last auditor was
Activist investor takes $1.9 billion stake in Southwest Airlines, calls for leadership changes
Elliott Investment Management announced Monday it has taken a $1.9 billion stake in Southwest Airlines and said there needs to be new leadership at
Aldeyra: A Speculative Buy Amid Reproxalap’s NDA Resubmission
Thesis Based on Aldeyra Therapeutics, Inc. (NASDAQ:ALDX)’s imminent catalysts (Reproxalap), considering the company holds $133 million in cash, cash equivalents and marketable securities, as
Most Read
